APO LMV 150 (Lamivudine 150 mg)
Pill with imprint APO LMV 150 is White, Four-sided and has been identified as Lamivudine 150 mg. It is supplied by Apotex Inc.
Lamivudine is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO LMV 150
Lamivudine
- Imprint
- APO LMV 150
- Strength
- 150 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Four-sided
- Availability
- Prescription only
- Drug Class
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Inc.
- Inactive Ingredients
-
lactose anhydrous,
crospovidone,
silicon dioxide,
hypromelloses,
hydroxypropyl cellulose,
magnesium stearate,
polyethylene glycol,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 60505-3251 | Apotex Corp. |
| 00904-6583 | Major Pharmaceuticals |
Related images for "APO LMV 150"
More about lamivudine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (5)
- Drug images
- Pricing & coupons
- En español
- Drug class: nucleoside reverse transcriptase inhibitors (NRTIs)
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.